智通财经APP获悉，天星医疗(01609)再涨超7%，月内累计涨幅逾35%。截至发稿，涨3.25%，报159港元，成交额3052.47万港元。
消息面上，天星医疗发布中期业绩，上半年实现收入约人民币1.63亿元，同比增长21.6%；经调整后的净利润约4889.7万元，同比增长24.3%，盈利增长主要得益于核心产品销量的大幅增长及有效的成本管控。
值得注意的是，公司加快国际市场拓展战略，这一举措显著提升了海外市场覆盖率及业务规模。期内来源于海外的销售收入约为4069.8万元，较2025年同期增长70.6%。海外收入占总收入的比例提升至24.9%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.